Success is built through seizing opportunities. Clay Siegall had an eye opener during his youthful years that made him decide to pursue a health-related career. Apart from earning it big financially, he resolved to assist cancer patients in the formulation of cancer drugs. As a result, he is the Founder and the CEO of Seattle Genetics, a biotech company that focuses on the development of targeted cancer therapy drugs.
Career choices are prompted by different reasons. For Clay Siegall, the decision was stimulated by the fact that medicine interested him since childhood. Moreover, the technology in the field seemed quite fascinating. With the new technologies, his interests became more vivid, and his focus was to experience the power of the advanced technology. Besides, he wanted to suppress the dominance of illnesses in the world.
Clay Siegall’s interest in medicine became more real during his college years. Unfortunately, his father fell ill and was diagnosed with cancer. The treatment at the time was brutal such that his father almost succumbed to death, not because of the chronic ailment but the adverse side-effects of the chemotherapy treatment. In his quest to seek better therapies, his desire was brought to life more than ever, and he went ahead to build a career on it. Over time, he has developed to be among the most prolific scientists focusing cancer therapies and treatments.
Clay Siegall has been the force behind his company’s development of proprietary drugs that have worked remarkably well. The continuous sale of the drugs has injected substantial revenues into his business. Clay attained a Bachelor’s of Science degree in Zoology from the University of Maryland. He is also a Ph.D. holder in Genetics from the University of George Washington.
Clay’s career at Seattle Genetics has been marked by incredible achievements. Also, he has worked for other highly reputable medical facilities. For instance, he has rendered his unique professional services at the National Institute of Health, Bristol-Myers Squibb Pharmaceutical Research Institute, and also the National Cancer Institute. Besides, Siegall sits on the Board of Alder BioPharmaceuticals. Clay has also authored numerous publications and holds about 15 patents. He attributes his achievements to his inbuilt passion, focus and hard work in his work.